Heart health company Omron Healthcare Inc reported on Thursday the receipt of US FDA clearance for Complete, the first blood pressure monitor with EKG capability in a single device.
The company will open Complete pre-orders on 15 April in the US on OmronHealthcare.com for USD199.99, with retail availability expanding to Amazon beginning 1 May 2019.
According to the company, Complete is an upper arm blood pressure monitor that allows users to simultaneously monitor EKG and blood pressure readings at home. EKG readings can be measured by touching electrodes located on the top face and both sides of the monitor for easy access and comfort.
EKG is an essential measurement for those with atrial fibrillation, also known as arrythmia or Afib, which can lead to increased risk of stroke and heart failure. Complete uses an advanced new algorithm for improved detection of the possibility of Afib along with medical-grade blood pressure measurement.
Saluda Medical secures CE certification for EVA Sensing Technology in Europe
Antin to acquire clinical trial equipment provider Emsere
Hyphens Pharma licenses Cerapro skin cream to Louis Widmer for six European markets
Profusa signs French distributor to expand Lumee Oxygen rollout in Europe
Sensiva Health names new chief operating officer
BrioHealth Solutions enrols 100th participant in BrioVAD System trial
Abbott's Amplatzer Piccolo Delivery System receives US FDA clearance and CE Mark
Amphix Bio announces initial closing of USD12.5m seed financing round
Bioretec wins FDA breakthrough status for biodegradable orthopaedic DrillPin
Amferia raises EUR3.5m to advance antimicrobial wound-care platform
BioCryst wins FDA approval for oral HAE prophylaxis in young children
ALR Technologies announces GluCurve Pet CGM relaunch in Canada
Galderma secures EU MDR certification for Sculptra, expanding use to multiple body areas
Clinical Laserthermia Systems applies for CE marking of ClearPoint Prism neuro laser system